Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis - A report of the International Study of Kidney Disease in Children

被引:118
作者
Tarshish, P [1 ]
Tobin, JN [1 ]
Bernstein, J [1 ]
Edelmann, CM [1 ]
机构
[1] ALBERT EINSTEIN COLL MED, BRONX, NY 10467 USA
关键词
nephrotic syndrome; focal segmental glomerulosclerosis; cyclophosphamide;
D O I
10.1007/s004670050167
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Sixty children, with biopsy diagnosed focal segmental glomerulosclerosis (FSGS) and with unremitting nephrotic syndrome despite intensive therapy with adrenocortical steroids, were randomly allocated into a clinical trial comparing prednisone, 40 mg/m(2) on alternate days for a period of 12 months (control group), with the same prednisone regimen plus a 90-day course of daily cyclo-phosphamide, 2.5 mg/kg in a single morning dose (experimental group). One-quarter of the children in each group had complete resolution of proteinuria. The proportions of children with increased, unchanged, and decreased proteinuria by the end of the study were the same in the two groups. Treatment failure was defined as an increase in serum creatinine of 30% or more or greater than 0.4 mg/dl, or onset of renal failure. Treatment failure occurred in 36% of the control group and 57% of the experimental group (P >0.1). Five patients died during the trial, 3 in the experimental group and 2 in the control group. A Kaplan-Meier survival analysis revealed no significant differences between the two groups. Cyclophosphamide therapy for children with steroid-resistant FSGS is not recommended.
引用
收藏
页码:590 / 593
页数:4
相关论文
共 31 条
[1]  
ABRAMOWI.M, 1970, LANCET, V1, P959
[2]  
[Anonymous], 1978, Kidney Int, V13, P159
[3]  
[Anonymous], 1974, LANCET, V2, P423
[4]  
BANFI G, 1991, CLIN NEPHROL, V36, P53
[5]   FOCAL GLOMERULOSCLEROSIS - NATURAL-HISTORY AND TREATMENT - REPORT OF 70 CASES [J].
BEAUFILS, H ;
ALPHONSE, JC ;
GUEDON, J ;
LEGRAIN, M .
NEPHRON, 1978, 21 (02) :75-85
[6]  
BROWN CB, 1978, CLIN NEPHROL, V10, P51
[7]  
CAMERON JS, 1978, CLIN NEPHROL, V10, P213
[8]  
CHURG J, 1970, LANCET, V1, P1299
[9]  
Cox D. R., 1984, ANAL SURVIVAL DATA
[10]  
FUTRAKUL P, 1978, CLIN NEPHROL, V10, P180